COLINZ LABORATORIES LTD. Share Price

COLINZ LABORATORIES LTD. Share Price

BSE: 531210
|
Pharmaceuticals

₹ 68.00

-₹2.02 (-2.88%)
1D
Last updated 13 Oct, 2026, 11:45 IST

COLINZ LABORATORIES LTD. Share Price Today

As of 13 Oct 2026, COLINZ LABORATORIES LTD. share price is ₹68.00. The stock opened at ₹67.30, compared to its previous close of ₹70.02. During today's trading session, COLINZ LABORATORIES LTD. share price moved in the range of ₹67.30 to ₹71.00, with an average price of ₹69.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹36.11 and a high of ₹87.91.

₹67.30
2.88% down today
₹71.00
1D LOW
1D HIGH

COLINZ LABORATORIES LTD. Returns Calculator

Volume
136
Average traded price
₹67.86
Last traded time
11:45:45 13 Oct
Last traded quantity
100
Circuit
L
H
₹63.02
₹77.02
52-week
L
H
₹36.11
₹87.91
Mkt Cap Cr
17.64
P/E
6.31
P/B
1.76
ROA
21.83%
ROE
5.12%
ROCE
7.05%
Quick Ratio
3.65
EV/EBITDA
2.82
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Colinz Labs outperforming most market indices
Step 3 of 5
Valuation
Fairly Valued
Colinz Labs appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,21,539.1634.795.0411.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9884.6414.7714.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.2221.084.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.224.18.57%18.59%17.35%0.9114.87
Laurus Labs1,09,796.85100.720.7210.38%16.77%16.14%0.6853.86
Cipla1,05,289.7831.373.067.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4131.332.625.48%11.07%12.54%1.3515.86
Mankind Pharma97,850.3847.326.07.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.152.566.34%9.25%11.76%1.1512.47
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About COLINZ LABORATORIES LTD.

COLINZ LABORATORIES LTD. Share Price
ISIN
INE923C01011
Sector Market Cap
₹ 17.64 Cr

Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.

COLINZ LABORATORIES LTD. Financial Highlights

  • Revenue: COLINZ LABORATORIES LTD. reported revenue of ₹6.62 crore in FY26 vs ₹6.83 crore in FY25. It showed a decrease of 3.07% on a yearly basis.
  • Operating Profit: COLINZ LABORATORIES LTD. reported an operating profit of ₹0.69 crore in FY26 vs ₹0.62 crore in FY25. It showed an increase of 11.29% on a year-on-year basis.
  • Net Profit: COLINZ LABORATORIES LTD. reported a net profit of ₹0.51 crore in FY26 vs ₹0.50 crore in FY25. It showed an increase of 2.00% on a yearly basis.

COLINZ LABORATORIES LTD. Quarterly Result Highlights

  • COLINZ LABORATORIES LTD. reported revenue of ₹1.36 crore in Jun 2026, compared with ₹1.92 crore in Mar 2026, representing a decrease of 29.17% on a quarter-on-quarter (QoQ) basis.
  • COLINZ LABORATORIES LTD. reported an operating profit of ₹2.90 crore in Jun 2026, compared with ₹0.22 crore in Mar 2026, representing an increase of 1,218.18% on a quarter-on-quarter (QoQ) basis.
  • COLINZ LABORATORIES LTD. reported a profit of ₹2.40 crore in Jun 2026, compared with ₹0.17 crore in Mar 2026, reflecting an increase of 1,311.76% on a QoQ basis.
  • The earnings per share (EPS) of COLINZ LABORATORIES LTD. stood at ₹2.04 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
50.60%
FII
0.00%
Other DII
0.00%
Retail and other
49.40%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
-4.12%
1 week
-4.08%
1 month
-3.42%
1 year
+63.41%
3 years
+75.05%
5 years
+221.19%
Day
Open / Close
Change %
12 Oct 26
₹74.13 / ₹70.02
-4.12%
09 Oct 26
₹74.99 / ₹73.03
-0.64%
08 Oct 26
₹73.50 / ₹73.50
+5.00%
07 Oct 26
₹71.85 / ₹70.00
-2.51%
Show more

COLINZ LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6.14₹6.53₹7.03₹7.15
Other Income₹0.48₹0.30₹0.28₹0.17
Total Revenue₹6.62₹6.83₹7.30₹7.33
Total Expenses₹5.93₹6.21₹6.65₹6.73
Profit Before Tax₹0.69₹0.62₹0.65₹0.60
Tax₹0.17₹0.12₹0.16₹0.14
Profit After Tax₹0.51₹0.50₹0.49₹0.46
EPS - Basic₹2.04₹1.97₹1.93₹1.82
EPS - Diluted₹2.04₹1.97₹1.93₹1.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.69₹0.62₹0.65₹0.60
Income before WC changes₹0.41₹0.50₹0.54₹0.63
Change in Assets₹1.92-₹1.73₹0.37₹0.06
Change in Liabilities₹0.40-₹0.02₹0.30-₹0.14
Change in WC₹2.32-₹1.75₹0.67-₹0.07
Cash flow from Operations₹2.54-₹1.45₹1.03₹0.40
Cash flow from Investing₹0.01-₹0.23₹0.01₹0.01
Cash flow from Financing₹0.43₹0.24₹0.23₹0.11
Total Cash Flow₹2.98-₹1.45₹1.27₹0.52
Cash (Start of the year)₹5.55₹7.00₹5.73₹5.21
Cash (End of the year)₹8.53₹5.55₹7.00₹5.73

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.70₹2.80₹2.62₹2.40
Current Assets₹10.08₹9.02₹8.74₹7.84
Total Assets₹12.78₹11.82₹11.36₹10.23
Current Liabilities₹2.57₹2.16₹2.18₹1.89
Net Current Asset₹7.51₹6.85₹6.55₹5.95
Non-Current Liabilities₹0.17₹0.18₹0.23₹0.21
Equity Capital₹10.04₹9.47₹8.95₹8.14
Total Equity & Liabilities₹12.78₹11.82₹11.36₹10.23
* All values are in INR Crore
Qty
Bid
495
68
500
67.5
71
67.3
100
67.1
70
67
Ask
Qty
71
539
72.5
500
72.9
100
75
50
0
0
Bid Total: 1236
Ask Total: 1189
Buy orders: 51%
Sell orders: 49%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
42.38
Neutral
ATR (14)
4.1
Neutral
STOCH(9,6)
30.84
Neutral
STOCH RSI (14)
10.8
Bullish
ADX(9)
30.38
Bearish
UO(9)
50.03
Neutral
ROC(12)
-5.25
Bearish
WillR(14)
-69.16
Neutral
Period
Simple value
Exponential vaue
5D
71.67
71.87
10D
73.12
72.62
20D
73.59
73.3
50D
75.44
73.52
100D
71.22
70.91
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
COLINZ LABORATORIES LTD. Share Price
COLINZ LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

COLINZ LABORATORIES LTD. Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.